Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Certain substances that block a specific protein help promote hair growth.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

The compound 4c showed strong potential as an anticancer agent.

Blocking certain immune signals can reduce skin damage from radiation therapy.

ITK inhibitors may effectively treat alopecia areata.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The treatment was ineffective in humans.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Promising cancer treatments were found, but the manufacturer closed.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Many patients on new leukemia drugs had mild to moderate skin reactions.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Tadalafil and Finasteride may help treat aggressive melanoma.

Suppressing ODC activity reduces tumor growth in hair follicles.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

JAK inhibitors show promise for treating various skin diseases.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.